Abstract
Rapid progress has been made in understanding the synaptic changes required for memory encoding. Several companies are now attempting to use information about the induction and consolidation phases of this process to build memory-enhancing drugs. These efforts have produced novel compounds that improve retention scores across a broad range of tests and species. Initial clinical results are encouraging. Issues now arise about appropriate applications of candidate drugs and optimal cellular targets for future development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bliss, T.V.P. & Lomo, T. Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path. J. Physiol. (Lond.) 232, 334–356 (1973).
Martin, S.J., Grimwood, P.D. & Morris, R.G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649–711 (2000).
Duncan, C.P. The retroactive effect of electroshock on learning. J. Comp. Physiol. Psychol. 42, 32–44 (1949).
Lynch, G. & Baudry, M. The biochemistry of memory: a new and specific hypothesis. Science 224, 1057–1063 (1984).
Malinow, R. & Malenka, R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25, 103–126 (2002).
Lee, H.K., Barbarosie, M., Kameyama, K., Bear, M.F. & Huganir, R.L. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405, 955–959 (2000).
Barrionuevo, G., Schottler, F. & Lynch, G. The effects of repetitive low frequency stimulation on control and “potentiated” synaptic responses in the hippocampus. Life Sci. 27, 2385–2391 (1980).
Dityatev, A., Dityateva, G. & Schachner, M. Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM. Neuron 26, 207–217 (2000).
Kramar, E.A., Bernard, J.A., Gall, C.M. & Lynch, G. Alpha3 integrin receptors contribute to the consolidation of long-term potentiation. Neuroscience 110, 29–39 (2002).
Nguyen, P.V. & Kandel, E.R. A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices. J. Neurosci. 16, 3189–3198 (1996).
Frey, U. & Morris, R.G. Synaptic tagging and long-term potentiation. Nature 385, 533–536 (1997).
Staubli, U., Rogers, G. & Lynch, G. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. USA 91, 777–781 (1994).
Arai, A., Kessler, M., Rogers, G. & Lynch, G. Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus. J. Pharmacol. Exp. Ther. 278, 627–638 (1996).
Hampson, R., Rogers, G., Lynch, G. & Deadwyler, S. Facilitative effects of the ampakine CX516 on short term memory in rats: correlations with hippocampal unit activity. J. Neurosci. 18, 2748–2763 (1998).
Pirotte, B. et al. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships. J. Med. Chem. 41, 2946–2959 (1998).
Baumbarger, P.J., Muhlhauser, M., Zhai, J., Yang, C.R. & Nisenbaum, E.S. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. J. Pharmacol. Exp. Ther. 298, 86–102 (2001).
Gates, M., Ogden, A. & Bleakman, D. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro. Neuropharmacology 40, 984–991 (2001).
Arai, A.C., Kessler, M., Rogers, G. & Lynch, G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol. Pharmacol. 58, 802–813 (2000).
Arai, A. & Lynch, G. AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices. Brain Res. 799, 235–242 (1998).
Dash, P.K., Hochner, B. & Kandel, E.R. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature 345, 718–721 (1990).
Barco, A., Alarcon, J.M. & Kandel, E.R. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 108, 689–703 (2002).
Yin, J.C. et al. Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila. Cell 79, 49–58 (1994).
Bourtchuladze, R. et al. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 59–68 (1994).
Kida, S. et al. CREB required for the stability of new and reactivated fear memories. Nat. Neurosci. 5, 348–355 (2002).
Yin, J.C., Del Vecchio, M., Zhou, H. & Tully, T. CREB as a memory modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell 81, 107–115 (1995).
Josselyn, S.A. et al. Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J. Neurosci. 21, 2404–2412 (2001).
Nagakura, A., Niimura, M. & Takeo, S. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br. J. Pharmacol. 135, 1783–1793 (2002).
Zhu, J., Mix, E. & Winblad, B. The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev. 7, 387–398 (2001).
Lauterborn, J.C., Lynch, G., Vanderklish, P., Arai, A. & Gall, C.M. Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J. Neurosci. 20, 8–21 (2000).
Mackowiak, M., O'Neill, M.J., Hicks, C.A., Bleakman, D. & Skolnick, P. An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology (in press)
Ingvar, M. et al. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146, 553–559 (1997).
Lynch, G. et al. Evidence that a positive modulator of AMPA-type glutamate receptors affects delayed recall in aged humans. Exp. Neurol. 145, 89–92 (1997).
Gainetdinov, R.R., Mohn, A.R., Bohn, L.M. & Caron, M.G. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc. Natl. Acad. Sci. USA 98, 11047–11054 (2001).
Goff, D.C. et al. A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. J. Clin. Psychopharmacol. 21, 484–487 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lynch, G. Memory enhancement: the search for mechanism-based drugs. Nat Neurosci 5 (Suppl 11), 1035–1038 (2002). https://doi.org/10.1038/nn935
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn935